iZafe Group invites shareholders and others to a Q&A session following the publishing of the first quarter report

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its first quarter report. The report will be available to the public on April 29, 2021 at 08:30 (8:30 a.m.) CET.

Questions will be answered by Chief Executive Officer Anders Segerström published on May 12, 2021 on iZafe's website under the heading Investor Relations.

Please send your questions tobefore 10:00 (10 a.m.) CET on May 3, 2021.

About Us

iZafe Group is a Swedish med-tech company that develops and markets medical and digital security solutions to create safer drug handling at home. Our digital medicine dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. Our products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafegroup.com/investorrelations.

iZafe Group invites shareholders and others to a Q&A session following the publishing of the first quarter report